SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-23-039586
Filing Date
2023-11-06
Accepted
2023-11-06 17:23:32
Documents
3

Document Format Files

Seq Description Document Type Size
1 formdefa14a.htm DEFA14A 16570
2 formdefa14a_001.jpg GRAPHIC 341500
3 formdefa14a_002.jpg GRAPHIC 268978
  Complete submission text file 0001493152-23-039586.txt   858886
Mailing Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005
Business Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40023 | Film No.: 231380843
SIC: 2834 Pharmaceutical Preparations